Snapshot from Jul 20, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / GeneDx class action lawsuit
Regulatory class action

GeneDx class action lawsuit

Analysis based on 16 articles · First reported Jul 10, 2026 · Last updated Jul 19, 2026

Sentiment
-30
Attention
2
Articles
16
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The lawsuit may negatively impact GeneDx's stock price due to potential liability and reputational damage. Investor confidence could be shaken, leading to increased volatility in the near term.

Healthcare Biotechnology
Event Summary

Bronstein, Gewirtz & Grossman, LLC, LLC filed a class action lawsuit against GeneDx Holdings Corporation and certain officers for alleged securities law violations. The complaint claims that between April 16, 2025 and May 4, 2026, GeneDx made false statements about Fabric Genomics' importance, reimbursement rates, and margins. Investors who purchased GeneDx securities during that period may seek lead plaintiff status by August 3, 2026.

Key Actions
98 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit GeneDx Holdings Corporation
94 GeneDx Holdings Corporation misled investors
89 Hagens Berman investigated claims GeneDx Holdings Corporation
86 GeneDx Holdings Corporation disclosed impairment loss Fabric Genomics
85 GeneDx Holdings Corporation reported financial results
45 GeneDx Holdings Corporation appointed new President Mark Gardner
Entities Involved
stock
GeneDx Holdings Corporation
GeneDx is the defendant in the class action lawsuit, facing allegations of misleading investors about its business operations and financial prospects.
Importance 100.0 Sentiment -40.0
priv
Bronstein, Gewirtz & Grossman, LLC
The law firm is representing investors in the class action, seeking damages for alleged securities fraud.
Importance 30.0 Sentiment 0.0
priv
Fabric Genomics
Mentioned in the complaint as a factor in alleged misleading statements about GeneDx's business.
Importance 20.0 Sentiment -10.0
per
Peretz Bronstein
Founding partner of Bronstein, Gewirtz & Grossman, LLC, involved in the class action filing.
Importance 10.0 Sentiment 0.0
per
Nathan Miller
Client Relations Manager at Bronstein, Gewirtz & Grossman, LLC, contact for investors.
Importance 5.0 Sentiment 0.0
Relationships
GeneDx Holdings Corporation related ↔ Bronstein, Gewirtz & Grossman, LLC
GeneDx Holdings Corporation parent ↔ Fabric Genomics GeneDx Holdings Corporation is the corporate parent and sole owner of Fabric Genomics, having acquired the company in Ma
Bronstein, Gewirtz & Grossman, LLC related ↔ Fabric Genomics
Bronstein, Gewirtz & Grossman, LLC related ↔ Peretz Bronstein
Bronstein, Gewirtz & Grossman, LLC related ↔ Nathan Miller
Peretz Bronstein employer ↔ Nathan Miller Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, where he employs and directs Nathan Miller
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.